Welcome to the e-CCO Library Archive!
T. Naftali1, L. Barlev2, G. Gabay1, Y. Chowers3, I. Dotan4, A. Stein1, M. Bronstein1, F.M. Konikoff1, 1Meir General Hospital, Gastroenterology, Kfar Saba, Israel, 2Tel aviv University, pschology, Tel Aviv, Israel, 3Rambam Health care campus, Gastroenterology, Haifa, Israel, 4Tel Aviv Sorasky Medical center, Gastroenterology, Tel Aviv, Israel
Long term efficacy of granulocyte-monocyte-apheresis in ulcerative colitis elderly patients. The Italian Registry of Therapeutic Apheresis.
R. Sacco*1, V. D'Ovidio2, A. Romano3, M. Bertini4, M. Bertoni4, G. Federici1, S. Metrangolo3, E. Tumino1, P. Giuseppe1, G. Bresci1, V. Mismas1, P. Vernia2
1Pisa University Hospital, Gastroenterology, Pisa, Italy, 2Policlinico Umberto I, Gastroenterology, Rome, Italy, 3Pisa University Hospital, Gastroenterology, Pisa, Italy, 4Pisa University Hospital, Gastroenterology , Pisa, Italy
Risk factors for pouchitis after laparoscopic ileal-pouch-anal anastomosis in patients with ulcerative colitis
R. Gonzalez1, L. Pereyra1, M. Omodeo1, E. Gómez1, J.M. Mella1, G.N. Panigadi1, C. Fischer1, B. Vizcaino1, A. Hadad1, M. Bun2, A. Canelas2, N. Rotholtz2, D.G. Cimmino1, S.C. Pedreira1, L.A. Boerr1, 1Hospital Alemán, Gastroenterology, Buenos Aires, Argentina, 2Hospital Alemán, Colorectal Surgery Section, Buenos Aires, Argentina
P. Hiroz1, N. Fournier2, E. Safroneeva3, S. Vavricka4, A. Schoepfer1, 1University Hospital Lausanne / CHUV, Gastroenterology and Hepatology, Lausanne, Switzerland, 2University of Lausanne, Institute of Social and Preventive Medicine, Lausanne, Switzerland, 3University of Bern, Institute of Social and Preventive Medicine, Bern, Switzerland, 4University Hospital Zurich, Gastroenterology and Hepatology, Zurich, Switzerland
Meta-analysis of the effects of anti- tumour necrosis factor alpha therapies on pregnancy outcomes in women with Inflammatory Bowel Disease
Z. Shihab1, N. Yeomans1, P. De Cruz*1, 2, 3
1Austin Health, Office of Research, Melbourne, Australia, 2Austin Health, Department of Gastroenterology, Melbourne, Australia, 3St Vincents Health, Department of Gastroenterology, Melbourne, Australia
Risk factors for complications after laparoscopic ileal-pouch-anal anastomosis in patients with ulcerative colitis
R. Gonzalez1, L. Pereyra1, M. Omodeo1, E. Gómez1, J.M. Mella1, G.N. Panigadi1, C. Fischer1, B. Vizcaino1, A. Hadad1, M. Bun2, A. Canelas2, N. Rotholtz2, D.G. Cimmino1, S.C. Pedreira1, L.A. Boerr1, 1Hospital Alemán, Gastroenterology, Buenos Aires, Argentina, 2Hospital Alemán, Colorectal Surgery Section, Buenos Aires, Argentina
A. Dignass1, B. Bokemeyer2, M. Mross3, M. Oudkerk Pool4, 1Agaplesion Markus Hospital, Frankfurt, Germany, 2Gastroenterologische Gemeinschaftspraxis, Minden, Germany, 3Internistische Praxis, Berlin, Germany, 4Gelre Ziekenhuizen, Apeldoorn, Netherlands
Adalimumab in perianal Crohn's disease treatment: Experience of a tertiary center
D. Carvalho*1, C. Bernardes1, P. Russo1, J. Saiote1, S. Nunes2, J. Ramos1
1Hospital Santo António dos Capuchos, Gastroenterology, Lisboa, Portugal, 2Hospital Santo António dos Capuchos, General Surgery, Lisboa, Portugal
Risk factors for symptom relapse in collagenous colitis after withdrawal of short-term budesonide therapy
S. Miehlke1, J.B. Hansen2, A. Madisch3, F. Schwarz4, E. Kuhlisch5, A. Morgner6, P.S. Teglbjaerg7, M. Vieth8, D. Aust9, O.K. Bonderup10, 1Magen-Darm-Zentrum, Facharztzentrum Eppendorf, Hamburg, Germany, 2Aalborg Hospital, Department of Gastroenterology, Aalborg, Denmark, 3Siloah Hospital, Medical Department I, Hannover, Germany, 4University Hospital, Medical Department III, Dresden, Germany, 5Technical University, Institute for Medical Informatics and Biometry, Dresden, Germany, 6Lanserhof Hamburg GmbH, LANS MEDICUM, Hamburg, Germany, 7Aalborg Hospital, Institute of Pathology, Aalborg, Denmark, 8Klinikum Bayreuth, Institute for Pathology, Bayreuth, Germany, 9University Hospital, Institute for Pathology, Dresden, Germany, 10Regional Hospital Silkeborg, Diagnostic Center, Section of Gastroenterology, Silkeborg, Denmark
T. Knittel1, R. Befrits2, R. Löfberg3, Å. Öst4, P. von Stein1, O. von Stein1, 1InDex Pharmaceuticals, Stockholm, Sweden, 2Dept. of Gastroenterology, Karolinska, Stcokholm, Sweden, 3IBD unit Sophiahemmet and the Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 4Aleris-Medilab AB, Stockholm, Sweden
Effects of azathioprine on outcome of pregnancy in Inflammatory Bowel Disease patients: A prospective study
L. Kecili*, N. Bounab, N. Kaddache, K. Layaida, T. Boucekkine, N. Debzi, S. Berkane
CHU Mustapha, Gastroenterology, Alger, Algeria
Retrospective comparison of the efficacy of anti-TNF agents in isolation or combined with azathioprine in prevention of early postoperative endoscopic recurrence in Crohn's disease from the MULTIPER database
Y. Suzuki1, P.G. Kotze2, A. Spinelli3,4, R. Saad-Hossne5, A. Yamada1, M. Sacchi3, F. Teixeira6, I. Albuquerque7, I. Barcelos2, R. Silva2, L. Kotze8, M. Olandoski9, S. Danese10, T. Yamamoto11, 1Toho University – Sakura Medical Center, Internal Medicine, Chiba, Japan, 2Cajuru University Hospital – Catholic University of Parana, Colorectal Surgery Unit, Curitiba, Brazil, 3Humanitas Research Hospital, Medical Biotechnologies and Translational Medicine, Milano, Italy, 4Humanitas Research Hospital, IBD Surgery Unit, Milano, Italy, 5São Paulo State University, Digestive Surgery Department, Botucatu, Brazil, 6Gastrosaude, Colorectal Surgery, Marilia, Brazil, 7Heliopolis Hospital, IBD unit, São Paulo, Brazil, 8Cajuru University Hospital – Catholic University of Parana, Gastroenterology, Curitiba, Brazil, 9Catholic University of Paraná, Statistics, Curitiba, Brazil, 10Humanitas Research Hospital, IBD Unit – Gastroenterology, Milano, Italy, 11Yokkaichi Social Insurance Hospital, IBD Unit, Yokkaichi, Japan